ESTHER ONEY: Open Payments
NPI 1902970544 · THURMONT, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,479 in 73 payments from 20 companies in 2025. Trend: 2023 $1,573 · 2024 $1,580 · 2025 $1,479
Food & beverage: $1,479
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $221 |
| Novo Nordisk Inc | 8 | $171 |
| Amgen Inc. | 10 | $164 |
| GlaxoSmithKline, LLC. | 5 | $102 |
| AstraZeneca Pharmaceuticals LP | 5 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $97 |
| Lilly USA, LLC | 5 | $95 |
| PFIZER INC. | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
Products named: JARDIANCE, TRELEGY ELLIPTA, QULIPTA, VRAYLAR, Ozempic, OTEZLA, MOUNJARO, EVENITY.
Industry payments across MD — which companies pay providers there.
